| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
6 companies
Chimovits Erez serves as a Director, 10% Owner at BRVE and has filed Form 4s across 6 companies. Across recent SEC filings that breaks down to 13 buys and 0 sells. Those positions are worth an estimated $249.8M at current prices.
The biggest single holding is BRVE (~$214.2M) as Director, 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 1,940,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | ADRX Adarx Pharmaceuticals, Inc. | Director | Buy | 61,516 | $17.00 | $1,045,772.00 | +0.7% | - | - | |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. Common Stock | Director, 10% Owner | Buy | 1,940,000 | $18.00 | $34,920,000.00 | -116.4% | - | - | |
| Oct 15, 2024 | UPB Upstream Bio, Inc. | Director, 10% Owner | Buy | 825,000 | $17.00 | $14,025,000.00 | +22.1% | -50.3% | -5.7% | |
| Dec 19, 2019 | PHGE Biomx Inc. | Director, 10% Owner | Buy | 4,000 | $8.90 | $35,615.00 | +0.2% | - | - | |
| Dec 11, 2019 | PHGE Biomx Inc. | Director, 10% Owner | Buy | 8,800 | $8.85 | $77,918.00 | +0.4% | - | - | |
| Dec 9, 2019 | PHGE Biomx Inc. | Director, 10% Owner | Buy | 10,200 | $8.40 | $85,646.00 | +0.4% | - | - | |
| May 2, 2019 | ELDN Eledon Pharmaceuticals, Inc. | Director | Buy | 646,204 | $3.10 | $2,003,232.40 | +25.5% | - | - |